» Articles » PMID: 35693789

Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche

Overview
Journal Front Immunol
Date 2022 Jun 13
PMID 35693789
Authors
Affiliations
Soon will be listed here.
Abstract

Although the role of microtubule dynamics in cancer progression is well-established, the roles of tubulin isotypes, their cargos and their specific function in the induction and sustenance of cancer stem cells (CSCs) were poorly explored. But emerging reports urge to focus on the transport function of tubulin isotypes in defining orchestrated expression of functionally critical molecules in establishing a stem cell niche, which is the key for CSC regulation. In this review, we summarize the role of specific tubulin isotypes in the transport of functional molecules that regulate metabolic reprogramming, which leads to the induction of CSCs and immune evasion. Recently, the surface expression of GLUT1 and GRP78 as well as voltage-dependent anion channel (VDAC) permeability, regulated by specific isotypes of β-tubulins have been shown to impart CSC properties to cancer cells, by implementing a metabolic reprogramming. Moreover, βIVb tubulin is shown to be critical in modulating EphrinB1signaling to sustain CSCs in oral carcinoma. These tubulin-interacting molecules, Ephrins, GLUT1 and GRP78, are also important regulators of immune evasion, by evoking PD-L1 mediated T-cell suppression. Thus, the recent advances in the field implicate that tubulins play a role in the controlled transport of molecules involved in CSC niche. The indication of tubulin isotypes in the regulation of CSCs offers a strategy to specifically target those tubulin isotypes to eliminate CSCs, rather than the general inhibition of microtubules, which usually leads to therapy resistance.

Citing Articles

Cell fusion as a driver of metastasis: re-evaluating an old hypothesis in the age of cancer heterogeneity.

Lopez-Collazo E, Hurtado-Navarro L Front Immunol. 2025; 16:1524781.

PMID: 39967663 PMC: 11832717. DOI: 10.3389/fimmu.2025.1524781.


GRP78 as a potential therapeutic target in cancer treatment: an updated review of its role in chemoradiotherapy resistance of cancer cells.

Lin M, Mo Y, Li C, Liu Y, Feng X Med Oncol. 2025; 42(2):49.

PMID: 39827214 DOI: 10.1007/s12032-024-02586-0.


Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer.

Beljkas M, Ilic A, Cebzan A, Radovic B, Djokovic N, Ruzic D Pharmaceutics. 2023; 15(11).

PMID: 38004560 PMC: 10674519. DOI: 10.3390/pharmaceutics15112581.


Ginsenosides on stem cells fate specification-a novel perspective.

Liu Y, Jiang L, Song W, Wang C, Yu S, Qiao J Front Cell Dev Biol. 2023; 11:1190266.

PMID: 37476154 PMC: 10354371. DOI: 10.3389/fcell.2023.1190266.


Prediction of anti-microtubular target proteins of tubulins and their interacting proteins using Gene Ontology tools.

Ramesh Babu P J Genet Eng Biotechnol. 2023; 21(1):78.

PMID: 37466845 PMC: 10356719. DOI: 10.1186/s43141-023-00531-8.


References
1.
Luan J, Zhang Q, Zhao K, Zhou X, Yao L, Zhang T . A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy. J Cancer. 2021; 12(12):3715-3725. PMC: 8120173. DOI: 10.7150/jca.51059. View

2.
Jurewicz E, Wyroba E, Filipek A . Tubulin-dependent secretion of S100A6 and cellular signaling pathways activated by S100A6-integrin β1 interaction. Cell Signal. 2017; 42:21-29. DOI: 10.1016/j.cellsig.2017.10.004. View

3.
Sirajuddin M, Rice L, Vale R . Regulation of microtubule motors by tubulin isotypes and post-translational modifications. Nat Cell Biol. 2014; 16(4):335-44. PMC: 4117587. DOI: 10.1038/ncb2920. View

4.
Bracey K, Ju M, Tian C, Stevens L, Wray D . Tubulin as a binding partner of the heag2 voltage-gated potassium channel. J Membr Biol. 2008; 222(3):115-25. DOI: 10.1007/s00232-008-9104-x. View

5.
Puurand M, Tepp K, Timohhina N, Aid J, Shevchuk I, Chekulayev V . Tubulin βII and βIII Isoforms as the Regulators of VDAC Channel Permeability in Health and Disease. Cells. 2019; 8(3). PMC: 6468622. DOI: 10.3390/cells8030239. View